Regeneron Pharma (REGN) PT Raised to $868 at Morgan Stanley
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $735.20 +0.05%
Rating Summary:
30 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Rating Summary:
30 Buy, 18 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 14 | Down: 15 | New: 50
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on Regeneron Pharma (NASDAQ: REGN) to $868.00 (from $851.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Argus Upgrades Regeneron Pharma (REGN) to Buy, 'attractive entry point '
- JPMorgan Upgrades Sandfire Resources NL (SFR:AU) (SNDFY) to Overweight
- Regeneron and Sanofi expand alliance with $1 Bln upfront deal
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
